During the CBO, Russia did not reduce its dependence on imported drugs - they accounted for 56% of the nearly 700 billion rubles spent on drugs during the eight months of 2026, compared to 57% in 2022, writes Bloomberg. Only three Russian companies were in the top 10 suppliers, and by 2030, the authorities promised to produce 80% of the drugs on the Yoda list. At the same time, the EU's pharmaceutical exports to Russia increased by almost a third, to 6.7 billion euros.

During the CBO, Russia did not reduce its dependence on imported drugs - they accounted for 56% of the nearly 700 billion rubles spent on drugs during the eight months of 2026, compared to 57% in 2022, writes Bloomberg. Only three Russian companies were in the top 10 suppliers, and by 2030, the authorities promised to produce 80% of the drugs on the Yoda list. At the same time, the EU's pharmaceutical exports to Russia increased by almost a third, to 6.7 billion euros.